JAK1/2 抑制剂治疗重症TAFRO综合征：一例报告 - Suppr | 超能文献

相似文献

1

JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report.JAK1/2 抑制剂治疗重症TAFRO综合征：一例报告

Ann Intern Med. 2021 May;174(5):719-721. doi: 10.7326/L20-1051. Epub 2021 Jan 12.

2

Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.96 例初发 Castleman 病中 7 例 TAFRO 综合征的临床特征和治疗：一项 10 年回顾性研究。

J Cancer Res Clin Oncol. 2020 Feb;146(2):357-365. doi: 10.1007/s00432-019-03120-w. Epub 2020 Jan 14.

3

Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report.

Eur J Haematol. 2020 Oct;105(4):505-507. doi: 10.1111/ejh.13473. Epub 2020 Jul 16.

4

A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.一例TAFRO综合征（多中心Castleman病的一种变异型）患者，经皮质类固醇和环孢素A成功治疗。

Mod Rheumatol. 2019 Jan;29(1):198-202. doi: 10.1080/14397595.2016.1206243. Epub 2016 Jul 14.

5

Ascites in the "TAFRO" Syndrome: Does the Squeeze Make the Juice?“TAFRO”综合征中的腹水：挤压能出汁吗？

Dig Dis Sci. 2020 Sep;65(9):2522-2526. doi: 10.1007/s10620-020-06433-w.

6

Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).患者出现肝弯曲杆菌空肠亚种感染（特发性多中心 Castleman 病伴血小板减少、全身性水肿、发热、网状纤维纤维化和器官肿大（TAFRO）综合征）。

Pathol Int. 2019 Oct;69(10):572-579. doi: 10.1111/pin.12856.

7

High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.泰国成人Castleman病患者中TAFRO综合征的高比例：十年经验

Ann Hematol. 2018 Jun;97(6):1019-1026. doi: 10.1007/s00277-018-3269-x. Epub 2018 Feb 20.

8

Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.环孢素A成功治疗托珠单抗耐药的TAFRO综合征

Intern Med. 2016;55(2):185-90. doi: 10.2169/internalmedicine.55.4710. Epub 2016 Jan 15.

9

Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.TAFRO综合征患者进行性肾脏受累的病理表现

CEN Case Rep. 2019 Nov;8(4):239-245. doi: 10.1007/s13730-019-00400-9. Epub 2019 May 10.

10

Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome.利妥昔单抗、类固醇脉冲疗法、血浆置换和罗米司亭联合治疗极重度TAFRO综合征取得成功。

Leuk Lymphoma. 2022 Oct;63(10):2499-2502. doi: 10.1080/10428194.2022.2074992. Epub 2022 May 13.

引用本文的文献

1

Multicentric Castleman disease presenting with orbital involvement progressing to TAFRO syndrome: a case report.多中心性Castleman病伴眼眶受累并进展为TAFRO综合征：一例报告

BMC Ophthalmol. 2025 Jul 22;25(1):421. doi: 10.1186/s12886-025-04251-0.

2

Pathophysiology, Treatment, and Prognosis of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome: A Review.血小板减少、全身性水肿、发热、网状纤维变性/肾衰竭及器官肿大（TAFRO）综合征的病理生理学、治疗与预后：综述

Curr Issues Mol Biol. 2024 Oct 9;46(10):11255-11269. doi: 10.3390/cimb46100668.

3

TAFRO Syndrome and COVID-19.